(-)-demecolcine decreases expression ISO RGD:69120 6480464 Demecolcine results in decreased expression of PAWR mRNA CTD PMID:23649840 (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA], alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein] CTD PMID:10428045 (S)-colchicine increases expression EXP 6480464 Colchicine results in increased expression of PAWR protein CTD PMID:12941380 (S)-colchicine multiple interactions EXP 6480464 alvocidib inhibits the reaction [Colchicine results in increased expression of PAWR protein] CTD PMID:12941380 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PAWR protein CTD PMID:15964511 17beta-estradiol multiple interactions EXP 6480464 Estradiol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA], Estradiol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein] CTD PMID:10428045 17beta-estradiol increases expression ISO RGD:69120 6480464 Estradiol results in increased expression of PAWR mRNA, Estradiol results in increased expression of PAWR protein CTD PMID:20106945 , PMID:20945400 17beta-estradiol multiple interactions ISO RGD:69120 6480464 EGF protein inhibits the reaction [Estradiol results in decreased expression of PAWR mRNA] CTD PMID:24758408 17beta-estradiol decreases expression ISO RGD:69120 6480464 Estradiol results in decreased expression of PAWR mRNA CTD PMID:24758408 1H-pyrazole increases expression ISO RGD:737403 6480464 pyrazole results in increased expression of PAWR mRNA CTD PMID:17945193 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PAWR mRNA CTD PMID:34747641 2-butoxyethanol increases expression ISO RGD:737403 6480464 n-butoxyethanol results in increased expression of PAWR mRNA CTD PMID:19812364 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of PAWR mRNA CTD PMID:19162173 4-hydroxyphenyl retinamide increases expression ISO RGD:737403 6480464 Fenretinide results in increased expression of PAWR mRNA CTD PMID:28973697 4-phenylbutyric acid decreases expression ISO RGD:69120 6480464 4-phenylbutyric acid results in decreased expression of PAWR mRNA CTD PMID:14583596 7,9-dihydro-1H-purine-2,6,8(3H)-trione multiple interactions EXP 6480464 Uric Acid inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA], Uric Acid inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein] CTD PMID:10428045 acrolein multiple interactions ISO RGD:69120 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PAWR mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PAWR mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO RGD:69120 6480464 Aflatoxin B1 results in increased expression of PAWR mRNA CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:69120 6480464 aflatoxin B2 results in increased methylation of PAWR intron CTD PMID:30157460 all-trans-retinoic acid affects localization ISO RGD:69120 6480464 Tretinoin affects the localization of PAWR protein CTD PMID:12644474 alpha-pinene multiple interactions ISO RGD:69120 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PAWR mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PAWR mRNA CTD PMID:32699268 alvocidib multiple interactions EXP 6480464 alvocidib inhibits the reaction [Colchicine results in increased expression of PAWR protein] CTD PMID:12941380 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PAWR mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:69120 6480464 Antirheumatic Agents results in increased expression of PAWR mRNA CTD PMID:24449571 aristolochic acid decreases expression ISO RGD:69120 6480464 aristolochic acid I results in decreased expression of PAWR mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:737403 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of PAWR mRNA CTD PMID:23650126 arsenous acid increases expression ISO RGD:69120 6480464 Arsenic Trioxide results in increased expression of PAWR mRNA, Arsenic Trioxide results in increased expression of PAWR protein CTD PMID:16966277 beauvericin decreases expression ISO RGD:69120 6480464 beauvericin results in decreased expression of PAWR mRNA CTD PMID:29203277 benzo[a]pyrene decreases expression ISO RGD:737403 6480464 Benzo(a)pyrene results in decreased expression of PAWR mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:69120 6480464 Benzo(a)pyrene affects the methylation of PAWR intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:737403 6480464 Benzo(a)pyrene results in increased expression of PAWR mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:69120 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PAWR mRNA CTD PMID:25181051 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PAWR gene CTD PMID:28505145 bortezomib multiple interactions ISO RGD:69120 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of PAWR mRNA CTD PMID:25522274 carbon nanotube increases expression ISO RGD:737403 6480464 Nanotubes, Carbon analog results in increased expression of PAWR mRNA CTD PMID:25554681 carboplatin decreases expression EXP 6480464 Carboplatin results in decreased expression of PAWR mRNA CTD PMID:18172885 choline multiple interactions ISO RGD:737403 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PAWR gene CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PAWR mRNA CTD PMID:18172885 cisplatin decreases expression ISO RGD:69120 6480464 Cisplatin results in decreased expression of PAWR mRNA CTD PMID:27392435 cisplatin decreases response to substance ISO RGD:69120 6480464 PAWR mutant form results in decreased susceptibility to Cisplatin CTD PMID:24144893 cisplatin multiple interactions ISO RGD:69120 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PAWR mutant form results in decreased susceptibility to Cisplatin] more ... CTD PMID:20705681 more ... cladribine multiple interactions ISO RGD:69120 6480464 Cladribine promotes the reaction [Bendamustine Hydrochloride results in decreased expression of PAWR protein] CTD PMID:12948851 clofibrate increases expression ISO RGD:737403 6480464 Clofibrate results in increased expression of PAWR mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:69120 6480464 cobaltous chloride results in increased expression of PAWR mRNA CTD PMID:19376846 copper(II) sulfate increases expression ISO RGD:69120 6480464 Copper Sulfate results in increased expression of PAWR mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:69120 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:69120 6480464 Coumestrol results in decreased expression of PAWR mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:69120 6480464 Cyclosporine results in increased expression of PAWR mRNA CTD PMID:20106945 , PMID:25562108 dextran sulfate decreases expression ISO RGD:737403 6480464 Dextran Sulfate results in decreased expression of PAWR protein CTD PMID:32272095 dextran sulfate multiple interactions ISO RGD:737403 6480464 Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PAWR protein] CTD PMID:32272095 diarsenic trioxide increases expression ISO RGD:69120 6480464 Arsenic Trioxide results in increased expression of PAWR mRNA, Arsenic Trioxide results in increased expression of PAWR protein CTD PMID:16966277 dibutyl phthalate increases expression ISO RGD:737403 6480464 Dibutyl Phthalate results in increased expression of PAWR mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PAWR mRNA CTD PMID:21266533 , PMID:21745491 dichloroacetic acid increases expression ISO RGD:737403 6480464 Dichloroacetic Acid results in increased expression of PAWR mRNA CTD PMID:28962523 dioxygen multiple interactions ISO RGD:737403 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAWR mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PAWR mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:69120 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA CTD PMID:19167446 fluoranthene multiple interactions ISO RGD:737403 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of PAWR mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:737403 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PAWR gene CTD PMID:20938992 folic acid decreases expression ISO RGD:737403 6480464 Folic Acid results in decreased expression of PAWR mRNA CTD PMID:25629700 furan decreases methylation EXP 6480464 furan results in decreased methylation of PAWR gene CTD PMID:27387713 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PAWR mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO RGD:69120 6480464 Hydrogen Peroxide affects the expression of PAWR mRNA CTD PMID:23410634 irinotecan decreases expression ISO RGD:69120 6480464 Irinotecan results in decreased expression of PAWR mRNA CTD PMID:20185912 isotretinoin decreases expression ISO RGD:69120 6480464 Isotretinoin results in decreased expression of PAWR mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:69120 6480464 Ivermectin results in decreased expression of PAWR protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:737403 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PAWR gene CTD PMID:20938992 leflunomide increases expression ISO RGD:69120 6480464 leflunomide results in increased expression of PAWR mRNA CTD PMID:28988120 LY294002 multiple interactions ISO RGD:69120 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PAWR mutant form results in decreased susceptibility to Cisplatin] CTD PMID:24144893 melatonin decreases expression EXP 6480464 Melatonin results in decreased expression of PAWR protein CTD PMID:15964511 menadione affects expression ISO RGD:69120 6480464 Vitamin K 3 affects the expression of PAWR mRNA CTD PMID:23410634 mercury dibromide increases expression ISO RGD:69120 6480464 mercuric bromide results in increased expression of PAWR mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAWR mRNA CTD PMID:27188386 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of PAWR mRNA CTD PMID:19564919 methylmercury chloride increases expression ISO RGD:69120 6480464 methylmercuric chloride results in increased expression of PAWR mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAWR mRNA CTD PMID:27188386 miglustat multiple interactions ISO RGD:737403 6480464 miglustat inhibits the reaction [[ST8SIA1 protein affects the abundance of Gangliosides] which results in decreased expression of PAWR protein] CTD PMID:11574545 N-nitrosodiethylamine increases expression ISO RGD:737403 6480464 Diethylnitrosamine results in increased expression of PAWR mRNA CTD PMID:24535843 nimesulide increases expression ISO RGD:69120 6480464 nimesulide results in increased expression of PAWR mRNA CTD PMID:10833474 NS-398 increases expression ISO RGD:69120 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of PAWR mRNA CTD PMID:10833474 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PAWR mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PAWR mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:69120 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PAWR mRNA more ... CTD PMID:32699268 p-menthan-3-ol increases expression ISO RGD:69120 6480464 Menthol results in increased expression of PAWR mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO RGD:69120 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of PAWR mRNA CTD PMID:20705681 paracetamol affects expression ISO RGD:737403 6480464 Acetaminophen affects the expression of PAWR mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PAWR mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:69120 6480464 Acetaminophen results in decreased expression of PAWR mRNA CTD PMID:27761495 perfluorooctanoic acid increases expression ISO RGD:69120 6480464 perfluorooctanoic acid results in increased expression of PAWR protein CTD PMID:26879310 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of PAWR mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:69120 6480464 Phenobarbital affects the expression of PAWR mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:69120 6480464 Phenylmercuric Acetate results in increased expression of PAWR mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAWR mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:737403 6480464 pirinixic acid results in increased expression of PAWR mRNA CTD PMID:18301758 potassium chromate decreases expression ISO RGD:69120 6480464 potassium chromate(VI) results in decreased expression of PAWR mRNA CTD PMID:22714537 propiconazole increases expression ISO RGD:737403 6480464 propiconazole results in increased expression of PAWR mRNA CTD PMID:21278054 raloxifene increases expression ISO RGD:69120 6480464 Raloxifene Hydrochloride results in increased expression of PAWR mRNA, Raloxifene Hydrochloride results in increased expression of PAWR protein CTD PMID:20945400 SB 431542 multiple interactions ISO RGD:69120 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SC-58125 increases expression ISO RGD:69120 6480464 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole results in increased expression of PAWR mRNA CTD PMID:10833474 silver atom increases expression ISO RGD:69120 6480464 Silver results in increased expression of PAWR mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:69120 6480464 Silver results in increased expression of PAWR mRNA CTD PMID:26014281 sodium arsenite increases expression ISO RGD:69120 6480464 sodium arsenite results in increased expression of PAWR mRNA, sodium arsenite results in increased expression of PAWR protein CTD PMID:16966277 sodium arsenite decreases expression ISO RGD:69120 6480464 sodium arsenite results in decreased expression of PAWR mRNA CTD PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of PAWR mRNA CTD PMID:19281266 sulindac sulfide increases expression ISO RGD:69120 6480464 sulindac sulfide results in increased expression of PAWR mRNA CTD PMID:10833474 sunitinib increases expression ISO RGD:69120 6480464 Sunitinib results in increased expression of PAWR mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:69120 6480464 Temozolomide results in increased expression of PAWR mRNA CTD PMID:31758290 tert-butyl hydroperoxide affects expression ISO RGD:69120 6480464 tert-Butylhydroperoxide affects the expression of PAWR mRNA CTD PMID:23410634 testosterone increases response to substance ISO RGD:737403 6480464 PAWR gene mutant form results in increased susceptibility to Testosterone CTD PMID:15877079 tetrachloromethane increases expression ISO RGD:737403 6480464 Carbon Tetrachloride results in increased expression of PAWR mRNA CTD PMID:31919559 tetrahydropalmatine decreases expression ISO RGD:69120 6480464 tetrahydropalmatine results in decreased expression of PAWR protein CTD PMID:20109541 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PAWR mRNA CTD PMID:23411599 , PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PAWR mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of PAWR mRNA CTD PMID:25729387 triadimefon decreases expression ISO RGD:69120 6480464 triadimefon results in decreased expression of PAWR mRNA CTD PMID:26705709 trichloroethene increases expression ISO RGD:737403 6480464 Trichloroethylene results in increased expression of PAWR mRNA CTD PMID:25549359 trichostatin A increases expression ISO RGD:69120 6480464 trichostatin A results in increased expression of PAWR mRNA CTD PMID:24935251 valproic acid increases methylation ISO RGD:69120 6480464 Valproic Acid results in increased methylation of PAWR gene CTD PMID:29154799 valproic acid increases expression ISO RGD:69120 6480464 Valproic Acid results in increased expression of PAWR mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:69120 6480464 Valproic Acid affects the expression of PAWR mRNA CTD PMID:25979313 vitamin E decreases expression ISO RGD:69120 6480464 Vitamin E results in decreased expression of PAWR mRNA CTD PMID:19244175
